COMP <GO>
SER vs IBIO // RETURN ON INVESTED CAPITAL (ROIC)
Serina Therapeutics Inc. (NYSE) VS. iBio Inc. (NASDAQ) • 15-METRIC TALLY: SER 2
— IBIO 2
■ METRIC PARITY
LAST: $1.85 (-4.64%) • MKT CAP: $49.3M
roic
-35.00%
LAST: $0.80 (+4.06%) • MKT CAP: $49.4M
roic
-35.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SER VS. IBIO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SER | IBIO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 132.10% | 77.80% | +54.30 | SER | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 4/9 | -1.00 | IBIO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.3 | 37.0 | +15.30 | SER | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $49.3M | $49.4M | -$156.1K | IBIO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SER REV | IBIO REV | SER GROSS % | IBIO GROSS % | SER FCF | IBIO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $130.0K | $400.0K | — | — | -$18.0M | -$15.3M |
| FY 2024 | $56.0K | $225.0K | — | — | -$17.2M | -$18.8M |
| FY 2023 | $3.2M | $82.2M | — | — | -$2.5M | -$30.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SER // BETA —
IBIO // BETA —